Scientists believe that
RATIONALE: It has been shown that about 30% of patients do not respond to immunosuppressive therapy or experience recurrence, and graft rejection and graft-versus-host-disease (GVHD) decrease event-free survival to 30% to 50% in the alternative donor (matched unrelated, partially matched family member) transplantation. Although an overall and disease free survival of 85% to 100%, can be obtained in allogeneic blood or
Aplastic anemia is a rare disease in which the bone marrow stops producing an adequate supply of blood cells. Any blood cells the marrow does make are completely normal, but there are simply not enough of them to serve the body's needs. With prompt and proper care, most patients can be successfully treated.